Our transcriptomic analyses demonstrate that cell lines weakly responsive to the combination treatments exhibited higher expression of genes in cancer hallmark pathways, such as EMT, PI3K/AKT/mTOR signaling and TGFβ signaling. The gene discussed is MTOR; the disease is cancer.